Curofy
Prostate cancer’s future seen in molecular tests
Current evidence suggests that molecular tests for prostate cancer are prognostic and can help clinicians and patients with difficult treatment decisions. In the not-too-distant future, gene tests could also guide choice of therapies.
See this content immediately after install